ag-1296 has been researched along with Benign Neoplasms, Brain in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Watanabe, T | 1 |
Ohtani, T | 1 |
Aihara, M | 1 |
Ishiuchi, S | 1 |
1 other study available for ag-1296 and Benign Neoplasms, Brain
Article | Year |
---|---|
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Model | 2013 |